Oxford Biotrans' Series B Round

Oxford Biotrans raised a round of funding on October 17, 2017.

Oxford Biotrans is committed to commercializing new enzymatic routes to high value speciality chemicals based on its cytochrome P450 enzyme technology. The first products to market will be flavors and…

Articles about Oxford Biotrans' Series B Round: